Geode Capital Management’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-475,472
| Closed | -$85.5M | – | 4110 |
|
|
2017
Q3 | $85.5M | Buy |
475,472
+17,770
| +4% | +$2.48M | 0.03% | 502 |
|
|
2017
Q2 | $47.4M | Buy |
457,702
+44,554
| +11% | +$3.64M | 0.02% | 675 |
|
|
2017
Q1 | $32.4M | Buy |
413,148
+68,145
| +20% | +$4.21M | 0.01% | 845 |
|
|
2016
Q4 | $15.5M | Buy |
345,003
+24,782
| +8% | +$1.22M | 0.01% | 1278 |
|
|
2016
Q3 | $17.9M | Buy |
320,221
+6,148
| +2% | +$343K | 0.01% | 1072 |
|
|
2016
Q2 | $15.7M | Buy |
314,073
+31,267
| +11% | +$1.54M | 0.01% | 1107 |
|
|
2016
Q1 | $13K | Buy |
282,806
+14,380
| +5% | +$697K | 0.01% | 1204 |
|
|
2015
Q4 | $16.5M | Buy |
268,426
+25,750
| +11% | +$1.81M | 0.01% | 1019 |
|
|
2015
Q3 | $13.5M | Buy |
242,676
+135,566
| +127% | +$8.53M | 0.01% | 1130 |
|
|
2015
Q2 | $6.53M | Buy |
107,110
+23,828
| +29% | +$1.36M | ﹤0.01% | 1719 |
|
|
2015
Q1 | $4.8M | Buy |
83,282
+14,641
| +21% | +$981K | ﹤0.01% | 1883 |
|
|
2014
Q4 | $3.96M | Buy |
68,641
+28,741
| +72% | +$1.21M | ﹤0.01% | 1968 |
|
|
2014
Q3 | $1.14M | Buy |
+39,900
| New | +$987K | ﹤0.01% | 2708 |
|
Geode Capital Management's KITE Position: Q4 2017 in Review
Geode Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 475,472 shares — an estimated $85.5M sold.
Geode Capital Management first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $85.5M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Geode Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Geode Capital Management sold 475,472 Kite Pharma, Inc. shares in Q4 2017, an estimated $85.5M.
- Geode Capital Management first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
- Geode Capital Management's Kite Pharma, Inc. position peaked at $85.5M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.